PDN
REGN icon

Pensionfund DSM Netherlands’s Regeneron Pharmaceuticals REGN Stock Holding History

Pensionfund DSM Netherlands’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,600
Closed -$1.01M – 353
2021
Q4 		$1.01M Hold
1,600
– – 0.12% 189
2021
Q3 		$968K Buy
+1,600
New +$993K 0.12% 191
2019
Q2 		– Sell
-6,200
Closed -$2.55M – 219
2019
Q1 		$2.55M Sell
6,200
-500
-7% -$206K 0.47% 96
2018
Q4 		$2.5M Buy
+6,700
New +$2.45M 0.5% 79

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pensionfund DSM Netherlands's REGN Position: Q1 2022 in Review

Pensionfund DSM Netherlands sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 1,600 shares — an estimated $1.01M sold.

Pensionfund DSM Netherlands first reported a position in REGN in Q4 2018 and held it in 4 quarters. The position peaked at $2.55M in Q1 2019. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

  • Pensionfund DSM Netherlands reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Pensionfund DSM Netherlands sold 1,600 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $1.01M.
  • Pensionfund DSM Netherlands first reported a position in Regeneron Pharmaceuticals in Q4 2018 and held it in 4 quarters.
  • Pensionfund DSM Netherlands's Regeneron Pharmaceuticals position peaked at $2.55M in Q1 2019.
  • 1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on Pensionfund DSM Netherlands's 13F filing for Q1 2022, filed 12 Apr 2022.